To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...

Quotient Sciences has successfully initiated a clinical study evaluating a novel drug product developed using AI ...

Hovione is bringing momentum to the intranasal field after announcing that its lead single-use nasal dry powder device, ...

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Actionable insights into research ...

Ensuring compatibility between an active pharmaceutical ingredient (API) and its excipients is a critical facet of drug development, influencing stability, efficacy and safety of the final dosage form ...

Spray-dried protein microparticles without MoNi surfactant form paste-like materials (left), whereas those spray dried with MoNi surfactant form injectable suspensions that flow like liquids (right).

Biologics are typically administered via injection and are thus best designed as liquid parenteral solutions. However, maintaining the stability of liquid biological products can be challenging. Many ...